Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to prospectively evaluate whether post-hepatectomy adjuvant
transcatheter arterial chemoembolization (TACE) is effective in reducing early recurrence in
HCC patients with preoperative CTC ≥2.
Phase:
Phase 4
Details
Lead Sponsor:
Fudan University
Collaborators:
Johnson & Johnson Medical, China Shanghai Zhongshan Hospital